Telerehabilitation in Progressive Multiple Sclerosis
Launched by UNIVERSITA DI VERONA · Jun 26, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective a combined rehabilitation approach can be for people with progressive forms of Multiple Sclerosis (MS). Specifically, it will look at whether a home-based digital telerehabilitation program, when paired with traditional in-hospital rehabilitation, can improve mobility better than just in-hospital rehabilitation alone. This is important because many individuals with progressive MS have limited treatment options and the goal is to find ways to help them move better and feel more independent.
To be eligible for this trial, participants must be between 18 and 75 years old and have been diagnosed with either primary or secondary progressive MS. They should also have mild to moderate balance issues that make them more likely to fall. Having a caregiver present is essential, and participants should be comfortable using digital technology. However, those with other medical conditions that affect movement or serious cognitive issues will not be included. If you join the study, you can expect to participate in both home and hospital rehabilitation activities, and your progress will be closely monitored to see how well this combined approach works.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-75;
- • Diagnosis of MS (primary or secondary progressive);
- • Mild to moderate balance impairments with increased fall risk, defined as TUG \> 8.4s;
- • A disability rate, as calculated using the Kurtzke Expanded Disability Status Scale (EDSS) lower than 7;
- • Acceptable level of digital skills;
- • The presence of the caregiver.
- Exclusion Criteria:
- • Other conditions that may affect motor function;
- • Impaired cognitive functioning (Mini-Mental Status Examination \<24/30);
- • Severe visual deficits (daltonism and visual acuity deficit);
- • Unable or refused to attend the rehabilitation treatment.
- • Patients who fulfill the following specified inclusion criteria will also undergo an EEG evaluation. However, ineligibility for this examination does not exclude them from participating in the rehabilitation study.
- The inclusion criteria for the EEG protocol will include:
- • The absence of metallic implants in the brain;
- • No history of brain surgery;
- • No use of medications that alter cortical excitability or are presumed to affect brain plasticity;
- • Right-handed dominance.
About Universita Di Verona
The Università di Verona is a prestigious academic institution in Italy, renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university collaborates with various healthcare professionals and institutions to explore new therapies and improve patient outcomes. Its research initiatives are driven by a multidisciplinary approach, leveraging cutting-edge technology and methodologies. The Università di Verona aims to contribute significantly to the scientific community and public health by fostering rigorous clinical studies that address pressing medical challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Verona, , Italy
Patients applied
Trial Officials
Marialuisa Gandolfi
Principal Investigator
Universita di Verona
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported